Activity in this selectioneli-lilly-and-company-3feff05c
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $52.5M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionNervonikDevelops peripheral nerve stimulation technologies for chronic pain and neurological conditions
Role not disclosed